Association of Angiotensin-converting Enzyme Gene Polymorphism with Susceptibility to Asthma Disease in Western Iran. 2022

Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
Department of Internal Medicine, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. amoini110@yahoo.com.

Asthma is a complex disease caused by a combination of multiple genetic and environmental factors. Angiotensin-converting enzyme (ACE) is involved in the pathogenesis of asthma by inactivating bradykinin, substance P, and neurokinin A. It has been shown that the level of ACE variation in serum is associated with an insertion-deletion (I/D) polymorphism. So, this study aimed to investigate the association of these polymorphisms with asthma in western Iran. In this case-control study, 111 asthmatic patients as a case group and 80 healthy subjects as a control group were evaluated. The ACE gene polymorphism was determined by the PCR method. The relationship between genotypes done by the χ2 test and the relative risk of disease with genetic polymorphism (Odds Ratio) was performed using logistic regression. The frequency of I/D genotypes (included in II, ID, and DD) between patient and control groups had no significant difference. In addition, none of the genotypes in the patient and control groups show any significant differences between men and women. However, the frequency of ID and DD genotypes was considerably different between the male patient groups (over and under 40 years old). Hence, these genotypes are suggested to be a risk factor for asthma. The results of our study indicate that ACE gene polymorphism is not significantly associated with asthma in the west of Iran.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000809 Angiotensins Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized. Angiotensin
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
November 1999, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
March 2000, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
January 2012, Allergologia et immunopathologia,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
December 1995, Journal of the American Society of Nephrology : JASN,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
December 2021, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
February 1994, Lancet (London, England),
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
August 2017, CNS neuroscience & therapeutics,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
August 2015, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
February 2017, Technology in cancer research & treatment,
Ali Moini, and Mohammad Reza Khirehgesh, and Amir Sarkhosh, and Atena Godarzi, and Asad Vaisi-Raygani, and Amir Kiani
March 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Copied contents to your clipboard!